Biopharma Companies Plan of Attack After COVID-19 Revenue Boom
The COVID era created new mass-market drugs and vaccines requiring substantial investments. However, investors and analysts urge companies to adapt [...]
Potential and Challenges of Blockchain Technology in Healthcare
Blockchain, a distributed ledger technology known for supporting cryptocurrencies, has garnered interest in the healthcare sector due to its ability [...]
U.S. Physicians Earn $350K Average; Study Reveals Impact on Overall System Costs
The average U.S. physician earns $350,000 annually, with top doctors making ten times that amount. A study using tax records [...]
Sarepta Therapeutics Begins Dosing Duchenne Patients with Newly Approved Gene Therapy
Sarepta Therapeutics has started dosing Duchenne muscular dystrophy patients with its recently approved gene therapy, Elevidys, and plans to serve [...]
Cost and Accessibility Concerns Over Lecanemab
The first drug aiming to slow the progression of Alzheimer's, lecanemab (brand name Leqembi), could cost the U.S. health care [...]
Medicare Drug Price Negotiations Predicted to Yield $1.8 Billion Savings by 2026
A new report asserts that the Inflation Reduction Act will enforce a minimum discount that surpasses the 2020 rebates for [...]
GSK Sues Pfizer Over Alleged RSV Vaccine Patent Infringement
Pharmaceutical companies GSK and Pfizer are engaged in a legal dispute over supposed patent infringement. GSK alleges that Pfizer’s respiratory [...]
NHS’s MedTech Strategy: Building Resilience, Innovation, Infrastructure, and Focused Markets for UK’s Future in Medical Technology
The Med-Tech Innovation Expo in June presented the NHS's medtech strategy. The NHS released this strategy in February 2023 and [...]
Infectious Disease Market Projected to Grow by 5.7% Led by Pfizer, Gilead Sciences, and GSK
According to a report by GlobalData, the infectious disease market is projected to grow actively from 2023 to 2029 and [...]
GSK Preps for Fall Launch of RSV Vaccine; CEO Expects Slower Initial Uptake
What You Need to Know: GSK has developed a vaccine against the respiratory syncytial virus (RSV) and is preparing to [...]
Biogen Plans Workforce Reduction and Refocuses on Lucrative Projects
Biogen has reported plans to cut 11.5% of its workforce, equating to about 1,000 employees, by 2025. This move forms [...]
Medlinker’s AI Doctors Almost Match Human Physicians in Groundbreaking Live Test
Medlinker, a Chinese digital healthcare company, hosted a live comparison of its AI doctors, MedGPT, and human doctors in Chengdu, [...]
Novo Nordisk Grapples with Supply Shortage Amid Surging Demand for Weight-Loss Drugs
Novo Nordisk is facing a supply shortage for its weight-loss drugs, Wegovy and Saxenda, due to surging demand… Here’s What [...]
ITIF Report: Global Drug Price Controls Restrict Pharmaceutical Research and Development
The Information Technology and Innovation Foundation (ITIF) study reports that drug price controls in non-US Organization for Economic Cooperation and [...]
Economists Suggest That Universal Coverage Is Already Possible for the US: What Obstacles Still Stand in the Way?
The current state of health insurance in the U.S. needs to be revised, even for insured Americans who face the [...]
FDA Approves AstraZeneca’s Beyfortus
The Food and Drug Administration has approved an AstraZeneca-developed monoclonal antibody, Beyfortus, in an effort to protect infants and young [...]
Revolution in Women’s Health: First Over-The-Counter Contraceptive Coming to U.S. Shelves in 2024!
Perrigo's oral contraceptive, Opill, is now the first over-the-counter birth control pill in the United States. Opill has been around [...]
BioGeneration Ventures Finalizes $167M Fund for Biotech Startups in Europe
What You Need To Know: Dutch venture capital firm BioGeneration Ventures (BGV) has secured €150 million ($167 million) for its [...]
Insights into the Global Real World Evidence Solutions Market 2023-2030
10 Things You Need to Know: The projection shows the market size growing from $16.3 billion in 2023 to $36.24 [...]
Unmasking Healthcare Costs: Beyond Transparency
What You Need to Know: Policymakers have shifted focus towards price transparency in healthcare to combat escalating costs; however, merely [...]
Price Break: Cigna Welcomes Trio of Discounted Biosimilars to Preferred Drug Roster
What You Need to Know: Cigna Group's unit, Express Scripts, is adding three biosimilar versions of AbbVie's arthritis treatment Humira [...]
Medicare Part D: Price Negotiation Panel Discussion
Hear expert panelists bring their perspectives on critical issues around support for Medicare Part D products' fair market prices.
Get to Know R-S-S (Regulatory Scientific and Health Solutions)
Supplier Spotlight® highlights the unique skills and services offered by organizations that are part of our CONNECTED COMMUNITY™. [...]
Health economic analysis of distributional equity impacts – a call to action
Standard cost-effectiveness analysis (CEA) does not provide the information about distributional equity impacts that decision makers need to reduce unjust differences in health by socioeconomic status, ethnicity and other aspects of social disadvantage.
Is Cost-Effectiveness Analysis Racist?
By: Michael Broder & Jesse Ortendahl Performing and using cost-effectiveness analyses is a core activity for many of us [...]
